Span Diagnostics is currently trading at Rs 39.00, up by 0.25 points or 0.65% from its previous closing of Rs 38.75 on the BSE.
The scrip opened at Rs 35.55 and has touched a high and low of Rs 39.60 and Rs 35.55 respectively. So far 3237 shares were traded on the counter.
The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 76.80 on 06-Apr-2011 and a 52 week low of Rs 25.00 on 19-Dec-2011.
Last one week high and low of the scrip stood at Rs 39.90 and Rs 35.05 respectively. The current market cap of the company is Rs 28.56 crore.
The promoters holding in the company stood at 44.18% while Non-Institutions held 55.82% of the stake.
Span Diagnostics has received a prestigious order worth Rs 21.45 crore from Ministry of Health & Family Welfare, Department of AIDS Control- National AIDS Control Organization, and Government of India through RITES for supply of HIV (Rapid) Test Kits. The deliveries are expected to be made within a period of nine months.
Span Diagnostics is a pioneer and trend setter of high quality products for pathology and clinical laboratories in the Indian diagnostics industry. It is a globally acknowledged and fastest growing diagnostic company with a successful track record of over 3 decades having Asia's one of the largest state-of-the-art ISO-9001:2000, WHO cGMP accredited advanced manufacturing facilities with ISO 13485 & CE accredited products.
| Company Name | CMP |
|---|---|
| BASF India | 3703.10 |
| Tata Chemicals | 709.05 |
| SRF | 2493.65 |
| Pidilite Inds. | 1393.25 |
| Deepak Nitrite | 1538.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: